Bioadaptives, Inc. (BDPT) Convertible Debt (2018 - 2026)

Bioadaptives (BDPT) posted Convertible Debt of $424211.0 for Q1 2026, up 36.4% sequentially from $311000.0 in Q3 2024.

Bioadaptives, Inc. (BDPT) Convertible Debt (2018 - 2026) Analysis & Trends

Bioadaptives has reported Convertible Debt for 8 years, with the latest figure at $424211.0 in Q1 2026.

Quarterly Convertible Debt changed N/A year-over-year to $424211.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $424211.0 (changed N/A YoY) and the FY2022 annual result came in at $381793.0, down 5.29% from the prior year.
Convertible Debt improved to $424211.0 in Q1 2026 per BDPT's latest filing, from $311000.0 in the prior quarter.
Over five years, Convertible Debt peaked at $440014.0 in Q2 2022 and troughed at $311000.0 in Q2 2024.
A 4-year average of $364360.3 and a median of $347336.0 in 2023 frame the typical range for Convertible Debt.
The sharpest annual moves came in 2022 and 2023: Convertible Debt gained 4.16% in 2022, then fell 28.24% in 2023.
Over 4 years, Convertible Debt stood at $381793.0 in 2022, then decreased by 14.7% to $325671.0 in 2023, then fell by 4.5% to $311000.0 in 2024, then jumped by 36.4% to $424211.0 in 2026.
According to Business Quant data, Convertible Debt over the past three periods registered $424211.0, $311000.0, and $311000.0 for Q1 2026, Q3 2024, and Q2 2024 respectively.

Download Data